Jin-Yuan Shih - Search Results

Year	Number of Results
2002	2
2003	2
2004	3
2005	8
2006	5
2007	6
2008	14
2009	4
2010	16
2011	19
2012	14
2013	6
2014	7
2015	15
2016	12
2017	19
2018	19
2019	18
2020	25
2021	25
2022	12
2023	20
2024	13

1

Perioperative Nivolumab in Resectable Lung Cancer.

Cascone T, Awad MM, Spicer JD, He J, Lu S, Sepesi B, Tanaka F, Taube JM, Cornelissen R, Havel L, Karaseva N, Kuzdzal J, Petruzelka LB, Wu L, Pujol JL, Ito H, Ciuleanu TE, de Oliveira Muniz Koch L, Janssens A, Alexandru A, Bohnet S, Moiseyenko FV, Gao Y, Watanabe Y, Coronado Erdmann C, Sathyanarayana P, Meadows-Shropshire S, Blum SI, Provencio Pulla M; CheckMate 77T Investigators. Cascone T, et al. N Engl J Med. 2024 May 16;390(19):1756-1769. doi: 10.1056/NEJMoa2311926. N Engl J Med. 2024. PMID: 38749033 Clinical Trial.

2

Cross-site validation of lung cancer diagnosis by electronic nose with deep learning: a multicenter prospective study.

Lee MR, Kao MH, Hsieh YC, Sun M, Tang KT, Wang JY, Ho CC, Shih JY, Yu CJ. Lee MR, et al. Among authors: shih jy. Respir Res. 2024 May 10;25(1):203. doi: 10.1186/s12931-024-02840-z. Respir Res. 2024. PMID: 38730430 Free PMC article.

3

ERBB2 Amplification in NSCLC: How Many Faces?

Shih JY. Shih JY. J Thorac Oncol. 2024 May;19(5):668-670. doi: 10.1016/j.jtho.2024.02.001. J Thorac Oncol. 2024. PMID: 38719422 No abstract available.

4

The association of EGFR amplification with aberrant exon 20 insertion report using the cobas EGFR Mutation Test v2.

Zhang MS, Yeh YC, Huang HN, Lin LW, Huang YL, Wang LC, Yao LJ, Hung TC, Tseng YF, Lee YH, Liao WY, Shih JY, Hsieh MS. Zhang MS, et al. Among authors: shih jy. PLoS One. 2024 Apr 30;19(4):e0301120. doi: 10.1371/journal.pone.0301120. eCollection 2024. PLoS One. 2024. PMID: 38687753 Free PMC article.

5

Next-generation sequencing reveals genetic heterogeneity and resistance mechanisms in patients with EGFR-mutated non-small cell lung cancer treated with afatinib.

Liang SK, Wei PF, Hsieh MS, Wu CL, Shih JY. Liang SK, et al. Among authors: shih jy. ERJ Open Res. 2024 Mar 18;10(2):00676-2023. doi: 10.1183/23120541.00676-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38500795 Free PMC article.

6

Dual-energy computed tomography for evaluating nodal staging in lung adenocarcinoma: correlation with surgical pathology.

Huang HC, Huang YS, Chang YC, Shih JY, Chen JS, Chang YC, Wang TC. Huang HC, et al. Among authors: shih jy. Jpn J Radiol. 2024 May;42(5):468-475. doi: 10.1007/s11604-023-01525-9. Epub 2024 Feb 5. Jpn J Radiol. 2024. PMID: 38311704

7

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants.

Nishino K, Shih JY, Nakagawa K, Reck M, Garon EB, Carlsen M, Matsui T, Visseren-Grul C, Nadal E. Nishino K, et al. Among authors: shih jy. JTO Clin Res Rep. 2023 Dec 19;5(2):100624. doi: 10.1016/j.jtocrr.2023.100624. eCollection 2024 Feb. JTO Clin Res Rep. 2023. PMID: 38304857 Free PMC article.

8

Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer.

Shih JY, Luo YH, Chang GC, Chang JW, Wang CC, Yang TY, Fang WT, Shau WY. Shih JY, et al. J Formos Med Assoc. 2024 Jan 8:S0929-6646(23)00499-0. doi: 10.1016/j.jfma.2023.12.019. Online ahead of print. J Formos Med Assoc. 2024. PMID: 38195317 Free article.

9

Comprehensive Genomic Analysis of Patients With Non-Small-Cell Lung Cancer Using Blood-Based Circulating Tumor DNA Assay: Findings From the BFAST Database of a Single Center in Taiwan.

Wang HY, Ho CC, Lin YT, Liao WY, Chen CY, Shih JY, Yu CJ. Wang HY, et al. Among authors: shih jy. JCO Precis Oncol. 2024 Jan;8:e2300314. doi: 10.1200/PO.23.00314. JCO Precis Oncol. 2024. PMID: 38190582 Free PMC article.

10

Tissue or liquid rebiopsy? A prospective study for simultaneous tissue and liquid NGS after first-line EGFR inhibitor resistance in lung cancer.

Lin YT, Ho CC, Hsu WH, Liao WY, Yang CY, Yu CJ, Tsai TH, Yang JC, Wu SG, Hsu CL, Hsieh MS, Huang YL, Wu CL, Shih JY. Lin YT, et al. Among authors: shih jy. Cancer Med. 2023 Dec 22;13(1):e6870. doi: 10.1002/cam4.6870. Online ahead of print. Cancer Med. 2023. PMID: 38140788 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

243 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

243 results

Results by year